Even though GLP-1 RAs seem to have a great potential to improve obesity-related metabolic and reproductive complications in PCOS, their use is currently not widely acknowledged and accepted in this population. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.